These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cutaneous vasculitides and the dermatologist: a fundamental part of clinical practice. Cozzani E; Caproni M G Ital Dermatol Venereol; 2015 Apr; 150(2):163-4. PubMed ID: 25876143 [No Abstract] [Full Text] [Related]
6. Cutaneous vasculitis update. Gibson LE Dermatol Clin; 2001 Oct; 19(4):603-15, vii. PubMed ID: 11705349 [TBL] [Abstract][Full Text] [Related]
7. Malignant pyoderma: a clinical variant of pyoderma gangrenosum. Erdi H; Anadolu R; Pişkin G; Gürgey E Int J Dermatol; 1996 Nov; 35(11):811-3. PubMed ID: 8915737 [No Abstract] [Full Text] [Related]
10. Koebner phenomenon in an ANCA-positive patient with pyoderma gangrenosum. Papi M; Didona B; Chinni LM; Gobello T; Mazzanti C; De Pità O; Cavalieri R J Dermatol; 1997 Sep; 24(9):583-6. PubMed ID: 9350105 [TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum developing over an arteriovenous fistula scar. Castillo RF; Cañadas-De la Fuente GA; Husein-Elahmed H; Cantero-Hinojosa J Intern Med J; 2011 May; 41(5):436-7. PubMed ID: 21605298 [No Abstract] [Full Text] [Related]
12. Vasculitis-What Do We Have to Know? A Review of Literature. Shavit E; Alavi A; Sibbald RG Int J Low Extrem Wounds; 2018 Dec; 17(4):218-226. PubMed ID: 30501545 [TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum; a rare complication of sclerotherapy. De Felice E; Allen B Phlebology; 2009 Oct; 24(5):213-4. PubMed ID: 19767488 [TBL] [Abstract][Full Text] [Related]